Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 92.5 pp 913-922
DOI: 10.1113/expphysiol.2007.037358
© The Physiological Society 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
92/5/913    most recent
expphysiol.2007.037358v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Magalhães-Nunes, A. P.
Right arrow Articles by Reis, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Magalhães-Nunes, A. P.
Right arrow Articles by Reis, L. C.
Neuroendocrinology/Endocrinology

Sertraline, a selective serotonin reuptake inhibitor, affects thirst, salt appetite and plasma levels of oxytocin and vasopressin in rats

Ana Paula de Magalhães-Nunes1, Daniel Badauê-Passos, Jr2,3, Renato Rizo Ventura2, Daniel da Silva Guedes, Jr4, Jacqueline Pereira Araújo1, Priscila Camargo Granadeiro1, Hevellyn Katarine Milanez-Barbosa1, Ricardo Henrique da Costa-e-Sousa1, Magda Alves de Medeiros1, José Antunes-Rodrigues2 and Luís Carlos Reis1

1 Department of Physiological Sciences, Institute of Biology, UFRuralRJ, Seropédica, RJ, Brazil 2 Department of Physiology, Faculty of Medicine of Ribeirão Preto, USP, Ribeirão Preto, SP, Brazil 3 Department of Psychology, University of Iowa, Iowa City, IA, USA 4 Department of Medicine and Surgery, Institute of Veterinary, UFRuralRJ, Seropédica, RJ, Brazil

We investigated the effects of chronic administration of sertraline (SERT; ~20 mg kg–1 day–1 in drinking water), a selective serotonin reuptake inhibitor, on water and sodium intake and on plasma levels of oxytocin (OT) and vasopressin (AVP) in basal and stimulated conditions. Basal water intake was reduced in SERT-treated rats. After 24 h of water deprivation, rats treated with SERT for 21 days ingested less water than the control rats (9.7 ± 0.5 versus 20.0 ± 0.9 ml, respectively, at 300 min after water presentation, P < 0.0001). Subcutaneous injection of 2 M NaCl or isoproterenol evoked a lower dipsogenic response in rats treated with SERT for 21 days. Fluid and food deprivation also induced a weaker dipsogenic response in SERT-treated rats (1.6 ± 0.5 versus 10.2 ± 1.2 ml, at 300 min, P < 0.0001) but had no effect on saline intake. Sodium depletion induced a higher natriorexigenic response in the SERT group (5.6 ± 1.3 versus 1.2 ± 0.3 ml, at 300 min, P < 0.0002). Higher urinary density and lower plasma sodium levels were observed after SERT treatment. Sertraline also increased plasma levels of vasopressin and oxytocin (AVP, 2.65 ± 0.36 versus 1.31 ± 0.16 pg ml–1, P < 0.005; OT, 17.16 ± 1.06 versus 11.3 ± 1.03 pg ml–1, P < 0.0009, at the third week post-treatment). These data constitute the first evidence that chronic SERT treatment affects water and sodium intake in rats. These effects seem to be related to the hyponatraemia caused by the higher plasma levels of AVP and OT.

(Received 20 February 2007; accepted after revision 14 June 2007; first published online 15 June 2007)
Corresponding author D. Badauê-Passos, Jr: 11 Seashore Hall E, Department of Psychology, University of Iowa, Iowa City, IA 52242, USA. Email: daniel-passosjunior{at}uiowa.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the The Physiological Society.